Press Release: Sunovion : Sunovion and Otsuka Initiate Clinical Development of Ulotaront for the Treatment of Generalized Anxiety Disorder

MARLBOROUGH, Mass. & PRINCETON, N.J.--(BUSINESS WIRE)-- #Sunovion--Sunovion and Otsuka Initiate Clinical Development of Ulotaront, a TAAR1 agonist, for the Treatment of Generalized Anxiety Disorder.